Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue

Journal of Pathology

Volumn 181, Issue 1, 1997, Pages 80-86

  Fernández, Pedro L ^a,f   Merino, María J ^c   Gómez, Mercedes ^b   Campo, Elías ^a   Medina, Teresa ^b   Castronovo, Vincent ^d   Sanjuán, Xavier ^a   Cardesa, Antonio ^a   Liu, Fu Tong ^e   Sobel, Mark E ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

^f HOSPITAL CLÍNIC   (Spain)

Author keywords

carcinoma; galectin 3; laminin; thyroid

Indexed keywords

GALECTIN 3; LAMININ; LECTIN; MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; PRIORITY JOURNAL; THYROID ADENOMA; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA;

ANTIGENS, DIFFERENTIATION; BLOTTING, NORTHERN; GALECTIN 3; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; LAMININ; RNA, MESSENGER; RNA, NEOPLASM; THYROID DISEASES; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0242499609     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199701)181:1<80::AID-PATH699>3.0.CO;2-E     Document Type: Article

References (48)

1. Castronovo V, Campo E, van den Brule FA, et al. Inverse modulation of steady-state messenger RNA levels of two non-integrin laminin-binding proteins in human colon carcinoma. J Natl Cancer Inst 1992; 84: 1161-1169.
2. Liotta LA. Tumor invasion and metastases: role of the extracellular matrix. Cancer Res 1986; 46: 1-7.
3. Wewer UM, Taraboletti G, Sobel ME, Albrechtsen R, Liotta LA. Role of laminin receptor in tumor cell migration. Cancer Res 1987; 47: 5691-5698.
4. Irimura T, Matsushita Y, Sutton RC, et al. Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Res 1991: 51: 387-393.
5. Raz A, Zhu D, Hogan V, et al. Evidence for the role of the 34-kDa galactoside-binding lectin in transformation and metastasis. Int J Cancer 1990; 46: 871-877.
6. Lotz MM, Andrews CW Jr, Korzelius CA, et al. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci USA 1993; 90: 3466-3470.
7. Demeure MJ, Damsky CH, Elfman F, Goretzki PE, Wong MG, Clark OH. Invasion by cultured human follicular cancer correlates with increased beta 1 integrins and production of proteases. World J Surg 1992; 16:770-776.
8. Vitale M, Bassi V, Fenzi G, Macchia PE, Salzano S, Rossi G. Integrin expression in thyroid cells from normal glands and nodular goiters. J Clin Endocrinol Metab 1993; 76: 1575-1579.
9. Barondes SH, Castronovo V, Cooper DNW, et al. Galectins: a family of animal β-galactoside-binding lectins. Cell 1994; 76: 597-598.
10. Castronovo V, Luyten F, van den Brule F, Sobel ME. Identification of a 14-kDa laminin binding protein (HLBP14) in human melanoma cells that is identical to the 14-kDa galactoside bindine lectin. Arch Biochem Biophys 1992; 297: 132-138.
11. Chiariotti L, Berlingieri MT, De Rosa P, et al Increased expression of the negative growth factor, galactoside-binding protein, gene in transformed thyroid cells and in human thyroid carcinoma. Oncogene 1992; 7: 2507-2511.
12. Jia S, Wang J, Carbohydrate binding protein 35. J Biol Chem 1988; 263: 6009-6011.
13. Ho MK, Springer TA, Mac-2, a novel 32.000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. J Immunol 1982; 128: 1221-1228.
14. Cherayil BJ, Weiner SJ, Pillai S. The Mac-2 antigen is a galactose-specific lectin that binds IgE. J Exp Med 1989; 170: 1959-1972.
15. Cherayil BJ, Chaitovitz S, Wong C, Pillai S. Molecular cloning of a human macrophage lectin specific for galactose. Proc Natl Acad Sci USA 1990; 87: 7324-7328.
16. Askew D, Burger CJ, Elgert KD. Tumor growth and adherence change the expression of macrophage Mac-2. Cancer Lett 1993; 69: 67-74.
17. Woo HJ, Shaw LM, Messier JM, Mercurio AM. The major non-integrin laminin binding protein of macrophages is identical to carbohydrate binding protein 35 (Mac-2). J Biol Chem 1990; 265: 7097-7099.
18. Liu FT, Albrandt K, Mendel E, Kulczycki AJ, Orida NK. Identification of an IgE-binding protein by molecular cloning. Proc Natl Acad Sci USA 1985; 82:4100-4104.
19. Albrandt K, Orida NK, Liu F-T. An IgE-binding protein with a distinctive repetition sequence and homology with an IgG receptor. Proc Natl Acad Sci USA 1987; 84: 6859-6863.
20. Robertson MV, Albrandt K, Keller D, Liu F-T. Human IgE-binding protein: a soluble lectin exhibiting a highly conserved interspecies sequence and differential recognition of IaE glycoforms. Biochemistry 1990; 29: 8093-8100.
21. Raz A, Lotan R, Endogenous galactoside-binding lectin: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastases Rel 1987; 6: 433-452.
22. Raz A, Pazerini G, Carmi P. Identification of the metastasis-associated galactoside-binding lectin as a chimeric gene product with homology to an IgE-binding protein. Cancer Res 1989; 49: 3489-3493.
23. Gitt MA, Barondes SH. Genomic sequence and organization of two members of a human lectin gene family. Biochemistry 1991; 30: 82-89.
24. Truong MJ, Gruart V, Kusnierz JP, et al. Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac-2/epsilonBP) of the S-type lectin family: role in IsE-dependem activation. J Exp Med 1993; 177: 243-248.
25. Bieber T. IgE-binding molecules on human Langerhans cells. Acta Derm Venereol (Stockholm) Suppl 1992; 176: 54-57.
26. Frigeri LG, Liu F-T. Surface expression of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages. J Immunol 1992; 148: 861-867.
27. Zhow Q. Cummings RD. The S-type lectin from calf heart tissue binds selectively to the carbohydrate chains of laminin. Arch Biochem Biophys 1990; 281: 27-35.
28. Xu X-C, El-Naggar AK, Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 1995; 147: 815-822.
29. Hsu DK, Zuberi RI, Liu F-T. Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin. J Biol Chem 1992; 267: 14167-14174.
30. Johnson TL, Lloyd RV, Thor A. Expression of ra.s oncogene p21 in normal and proliferative thyroid tissue. Am J Pathol 1987; 127: 60-65.
31. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang S-H. Koeffler HP. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinoma. J Clin Invest 1993; 91: 179-184.
32. Frauman AG, Moses AC. Oncogenes and growth factors in thyroid carcinogenesis. Endocrinol Metab Clin North Am 1990; 19: 479-493.
33. Rosenberg IM, lyer R, Cherayil B, Chiodino C, Pillai S. Structure of the murine Mac-2 gene. Splice variants encode proteins lacking functional signal peptide. J Biol Chem 1993; 268: 12393-12400.
34. Moutsatsos IK, Davis JM, Wang JL. Endogenous lectins from culture cells: subcellular localization of carbohydrate-binding protein 35 in 3T3 fibroblasts. J Cell Biol 1986; 102: 477-483.
35. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ('insular') thyroid carcinoma. A reinterpretation of Langhans" 'wuchernde struma'. Am J Surg Pathol 1984; 8: 655-668.
36. Papotti M, Botto Micca F, Favero A, Palestini N, Bussolati G. Poorly differentiated thyroid carcinoma with primordial cell component. A group of aggressive lesions sharing insular, trabecullar and solid patterns. Am J Surg Pathol 1993; 17: 291-301.
37. Carcangiu ML, Steeper T, Zampi G. Rosai J. Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol 1985; 83: 135-158.
38. Hutter RVP, Tollefsen HR. De Cosse JJ, Foote FW Jr, Frazell EL. Spindle and giant cell metaplasia in papillary carcinoma of the thyroid. Am J Surg 1965; 110: 660-668.
39. Fisher ER. Gregorio R, Shoemaker R, Horvart B, Hubay C. The derivation of so-called 'giant-cell' and 'spindle-cell' undifferentiated thyroidal neoplasm. Am J Clin Pathol 1974; 61: 680-689.
40. Harada T, Ito K, Shimaoka K, Hosoda Y, Yakumaru K. Fatal thyroid carcinoma. Anaplastic transformation of adenocarcinoma. Cancer 1977; 39: 2688-2696.
41. Aldinger KA, Samaan NA, Ibanez M, Hill CS Jr. Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid. Cancer 1978; 41: 2267-2275.
42. Campo E, Perez M, Charonis AA, Axiotis CA, Merino MJ. Patterns of basement membrane laminin distribution in nonneoplastic and neoplastic thyroid tissue. Mod Pathol 1992; 5: 540-546.
43. Miettinen M, Virtanen I. Expression of laminin in thyroid gland and thyroid tumors. An immunohistological study. Int J Cancer 1984; 34: 27-30.
44. Kendall CH, Sanderson PR, Cope J, Talbot IC. Follicular thyroid tumors: a study of laminin and type IV collagen in basement membrane and endothelium. J Clin Pathol 1985; 38: 1100-1105.
45. Rosenberg I, Cherayil RJ, Isselbacher KJ, Pillai S. Mac-2-binding glycoproteins. Putative ligands for a cytosolic beta-galactoside lectin. J Biol Chem 1991; 266: 18731-18736.
46. Koths K, Taylor E, Halenbeck R, Casipit C, Wang A. Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J Biol Chem 1993; 268: 14245-14249.
47. Liotta LA. Tumor invasion and metastases: role of the basement membrane. Am J Pathol 1984; 117: 339-348.
48. Campo E, Merino E, Liotta LA, Neumann R, Stetler-Stevenson W. Distribution of the 72-kD type IV collagenase in nonneoplastic and neoplastic thyroid tissue. Hum Pathol 1992; 23: 1395-1401.